Shamema Nasrin is the Drug Metabolism and Disposition Highlighted Trainee Author for the December 2021 issue. She is currently a final year Ph.D. candidate in the graduate program in pharmaceutical sciences and molecular medicine at Washington State University. Her mentor is Dr. Philip Lazarus. The DMD articles that earned her the title of Highlighted Trainee Author are companion papers titled "Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and their Metabolites" and "Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions" and are available at: https://doi.org/10.1124/dmd.121.000530 and https://doi.org/10.1124/dmd.121.000442.
Ms. Nasrin’s current research interests include drug metabolism, focusing on understanding the in vitro inhibitory potential of cannabinoids and their metabolites, as well as the consequences for tobacco and cannabis co-use.
The anticipated impact of Ms. Nasrin’s research is to pave the way for future studies on clinically relevant interactions between cannabis and tobacco components. Dual consumers of tobacco and cannabis-derived products have increased substantially in the United States and many other countries across the world in recent years, prompting the creation of credible data describing the possible interactions between tobacco and cannabis components.
When not in the lab, Shamema enjoys spending time with her family, cooking, and crocheting.